Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

BNGO

Bionano Genomics Inc

Dec 26 • 10:29AM ET

0.2034

Dollar change +0.0010
Percentage change 0.49	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: ILMN PACB CDNA FLGT QGEN MYGN TWST BGNE GH TXG

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.31	Insider Own	0.51%	Shs Outstand	101.99M	Perf Week	-3.14%
Market Cap	20.74M	Forward P/E	-	EPS next Y	-0.31	Insider Trans	0.00%	Shs Float	101.47M	Perf Month	-19.09%
Income	-135.78M	PEG	-	EPS next Q	-0.13	Inst Own	5.35%	Short Float	15.61%	Perf Quarter	-53.92%
Sales	33.33M	P/S	0.62	EPS this Y	77.19%	Inst Trans	-18.94%	Short Ratio	5.46	Perf Half Y	-72.31%
Book/sh	0.55	P/B	0.37	EPS next Y	80.04%	ROA	-100.85%	Short Interest	15.84M	Perf Year	-89.68%
Cash/sh	0.23	P/C	0.90	EPS next 5Y	-	ROE	-161.77%	52W Range	0.19 - 2.27	Perf YTD	-89.24%
Dividend Est.	-	P/FCF	-	EPS past 5Y	23.59%	ROI	-250.76%	52W High	-91.04%	Beta	2.28
Dividend TTM	-	Quick Ratio	0.99	Sales past 5Y	32.87%	Gross Margin	-1.80%	52W Low	4.85%	ATR (14)	0.02
Dividend Ex-Date	-	Current Ratio	1.43	EPS Y/Y TTM	66.91%	Oper. Margin	-287.53%	RSI (14)	35.59	Volatility	7.00% 9.24%
Employees	344	Debt/Eq	0.46	Sales Y/Y TTM	-0.82%	Profit Margin	-407.34%	Recom	3.00	Target Price	1.00
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	83.98%	Payout	-	Rel Volume	1.25	Prev Close	0.20
Sales Surprise	-21.71%	EPS Surprise	-213.11%	Sales Q/Q	-34.83%	Earnings	Nov 13 AMC	Avg Volume	2.90M	Price	0.20
SMA20	-10.81%	SMA50	-21.67%	SMA200	-66.36%	Trades		Volume	702,282	Change	0.49%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-24	Downgrade	Ladenburg Thalmann	Buy → Neutral
Sep-10-24	Downgrade	BTIG Research	Buy → Neutral
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$4
Dec-12-22	Resumed	BTIG Research	Buy	$3.50
Jul-18-22	Resumed	Oppenheimer	Outperform	$12
Jun-16-21	Initiated	BTIG Research	Buy	$10
Sep-24-20	Initiated	Ladenburg Thalmann	Buy	$1.25
Apr-08-20	Initiated	Oppenheimer	Outperform	$1.50

Dec-23-24 08:30AM	Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis (GlobeNewswire)
Dec-19-24 08:00AM	Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal (GlobeNewswire)
Dec-10-24 08:00AM	Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell and Gene Therapy (GlobeNewswire) -5.96%
08:00AM	Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy (GlobeNewswire)
Nov-14-24 02:15AM	Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... (GuruFocus.com) -7.58%
08:45PM	Loading…
Nov-13-24 08:45PM	Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript (Motley Fool)
04:01PM	Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress (GlobeNewswire)
Nov-07-24 04:01PM	Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024 (GlobeNewswire) -5.26%
Oct-31-24 04:30PM	Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (GlobeNewswire) -14.49%
08:10AM	Bionano Adjourns Special Meeting of Stockholders to November 27, 2024 (GlobeNewswire)
08:00AM	Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (GlobeNewswire)
Oct-24-24 08:00AM	Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma (GlobeNewswire)
Oct-10-24 08:00AM	Bionano Announces Preliminary 3Q 2024 Revenues and Cash (GlobeNewswire) -11.99%
Oct-09-24 05:18PM	Bionano Genomics Inc (BNGO) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Oct-03-24 08:00AM	Bionano Adjourns Special Meeting of Stockholders to October 30, 2024 (GlobeNewswire)
09:55AM	Loading…
Sep-06-24 09:55AM	Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now (Zacks)
Sep-04-24 08:00AM	Bionano to Present at the H.C. Wainwright 26 Annual Global Investment Conference (GlobeNewswire)
Aug-13-24 12:00PM	Bionano Genomics (BNGO) Upgraded to Buy: Here's Why (Zacks) +8.87%
Aug-08-24 12:15AM	Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript (Motley Fool) -6.72%
Aug-07-24 11:53PM	BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace) -15.88%
04:01PM	Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress (GlobeNewswire)
Aug-01-24 08:00AM	Bionano Announces Presentation of Optical Genome Mapping Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting (GlobeNewswire) -8.45%
Jul-31-24 04:01PM	Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
08:00AM	Bionano to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 7, 2024 (GlobeNewswire)
Jul-23-24 08:00AM	Bionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple Myeloma (GlobeNewswire)
Jul-16-24 06:30AM	3 Quantum AI Stocks That Could Redefine Computing (InvestorPlace) +5.14%
Jul-08-24 05:25PM	Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) +12.68%
Jul-05-24 08:00AM	Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Jul-02-24 08:00AM	Scientific Presentations Highlight OGM's Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations (GlobeNewswire) -13.91%
08:00AM	Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting (GlobeNewswire)
08:00AM	Loading…
Jun-20-24 08:00AM	Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research (GlobeNewswire)
Jun-17-24 04:05PM	Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis (GlobeNewswire)
May-30-24 08:00AM	Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow (GlobeNewswire)
May-28-24 02:01PM	3 Sorry Healthcare Stocks to Sell in May While You Still Can (InvestorPlace)
08:00AM	Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet (GlobeNewswire)
May-21-24 08:00AM	Bionano Announces Three Publications Demonstrating OGM's Utility for Cell and Gene Therapy (GlobeNewswire)
May-10-24 08:00AM	The 3 Best Healthcare Stocks to Buy in May 2024 (InvestorPlace)
May-09-24 12:08PM	Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2024 Earnings Call Transcript (Insider Monkey) +6.79%
08:00AM	Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis (GlobeNewswire)
06:03AM	Q1 2024 Bionano Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
03:44AM	Bionano Genomics Inc (BNGO) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ... (GuruFocus.com)
May-08-24 08:58PM	BNGO Stock Earnings: Bionano Genomics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:30PM	Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript (Motley Fool)
04:01PM	Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress (GlobeNewswire)
May-01-24 08:00AM	Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024 (GlobeNewswire) +8.54%
Apr-30-24 04:05PM	Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference (GlobeNewswire)
Apr-25-24 01:10PM	3 Contrarian Investments to Make Now for Massive Upside Potential (InvestorPlace)
Apr-24-24 08:00AM	Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing (GlobeNewswire)
Apr-17-24 08:00AM	Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence (GlobeNewswire)
Apr-11-24 08:00AM	Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing (GlobeNewswire)
Apr-04-24 01:44PM	Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Apr-03-24 08:00AM	Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics (GlobeNewswire)
Apr-02-24 08:00AM	Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys System at the American Association for Cancer Research Annual Meeting (GlobeNewswire) -6.78%
Mar-19-24 08:00AM	Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance (GlobeNewswire)
Mar-07-24 11:47AM	Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:00AM	Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company's New Stratys System (GlobeNewswire)
Mar-06-24 06:44AM	Q4 2023 Bionano Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
12:30AM	Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript (Motley Fool)
Mar-05-24 11:51PM	BNGO Stock Earnings: Bionano Genomics Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:01PM	Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024 (GlobeNewswire)
Feb-29-24 08:00AM	Bionano to Present at TD Cowen's 44th Annual Health Care Conference (GlobeNewswire)
Feb-28-24 08:01AM	Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024 (GlobeNewswire)
08:00AM	Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway (GlobeNewswire)
Feb-22-24 08:00AM	American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis (GlobeNewswire)
Feb-07-24 01:10PM	7 Penny Stocks to Buy on the Dip: February 2024 (InvestorPlace)
Jan-31-24 08:00AM	Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -5.60%
Jan-30-24 08:00AM	Bionanos Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS (GlobeNewswire)
Jan-25-24 08:00AM	Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer (GlobeNewswire)
Jan-24-24 08:00AM	Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing (GlobeNewswire) -6.06%
Jan-23-24 08:00AM	Bionano Announces Full Commercial Release of the Stratys System for High Throughput Optical Genome Mapping (GlobeNewswire)
Jan-19-24 08:00AM	Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications (GlobeNewswire)
Jan-17-24 05:53AM	Contrarian Kings: 3 Unloved Stocks That Could Be the Next Market Darlings (InvestorPlace)
Jan-11-24 04:01PM	Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing (GlobeNewswire) -7.79%
Jan-10-24 08:00AM	Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications (GlobeNewswire) -5.52%
Jan-08-24 08:00AM	Bionano Reports Preliminary Fourth Quarter and Full-Year 2023 Results (GlobeNewswire) +7.23%
Jan-03-24 08:00AM	OGM Added to International System for Human Cytogenomic Nomenclature (GlobeNewswire) -7.50%
08:00AM	International Consortium Publishes Comprehensive Roadmap for the Clinical Implementation of OGM in Hematological Malignancy Applications (GlobeNewswire)
Dec-28-23 08:00AM	Bionano Announces Significant Upgrades to its Bionano Solve Pipeline and its VIA Software for OGM Data Analysis in Constitutional Genetic Disease Research (GlobeNewswire)
Dec-26-23 08:00AM	Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping (GlobeNewswire) +16.57%
Dec-14-23 08:00AM	Cancers Journal Publishes Special Issue Dedicated to OGM's Impact on Hematological Malignancy Research (GlobeNewswire) +8.67%
Dec-12-23 08:00AM	Bionano Laboratories Announces Publication of the Analytical Validation of its OGM-Based Laboratory Developed Test for Hematological Malignancies and Additional Multi-Site Technical Evaluation of OGM (GlobeNewswire)
Dec-06-23 08:00AM	Bionano Announces Presentations Featuring OGM Utility Across Blood Cancer Research at the American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
Dec-05-23 06:00AM	Wealth Accumulation: 3 Stocks with Multibagger Potential (InvestorPlace) -8.33%
Nov-30-23 08:00AM	Study Shows that OGM Plays an Important Role in Efficient Diagnosis of FSHD (GlobeNewswire)
Nov-29-23 10:04AM	Bionano Announces Publication Demonstrating Utility of OGM to Assess Genome Integrity of CRISPR-Edited Cells as Part of Gene Therapy Development (GlobeNewswire)
Nov-17-23 09:35AM	After Plunging -23.84% in 4 Weeks, Here's Why the Trend Might Reverse for Bionano Genomics, Inc. (BNGO) (Zacks)
Nov-15-23 12:07AM	LeddarTech Appoints Chris Stewart as Chief Financial Officer (GlobeNewswire)
Nov-14-23 08:00AM	Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting (GlobeNewswire) +9.38%
Nov-10-23 05:00AM	3 Stocks That Are Poised to Generate Outsized Returns (InvestorPlace)
Nov-09-23 10:36AM	Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 08:00PM	Bionano Genomics (BNGO) Q3 2023 Earnings Call Transcript (Motley Fool)
06:19PM	Bionano Genomics Inc (BNGO) Reports Growth in Q3 2023 Amidst Strategic Cost-Saving Initiatives (GuruFocus.com)
04:01PM	Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress (GlobeNewswire)
Nov-02-23 08:00AM	Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow's Performance and Ability to Detect More SVs than LRS at Lower Cost (GlobeNewswire) +12.03%
Nov-01-23 04:05PM	Bionano to Present at the 2023 Stifel Healthcare Conference (GlobeNewswire)
08:00AM	Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 (GlobeNewswire)
Oct-27-23 12:28PM	3 Deeply Undervalued Growth Stocks to Buy in November (InvestorPlace)
Oct-26-23 10:02AM	Will Bionano Genomics, Inc. (BNGO) Report Negative Q3 Earnings? What You Should Know (Zacks)
08:00AM	Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting (GlobeNewswire)
Oct-11-23 08:05AM	Bionano Prices $80.0 Million Financing in Convertible Notes and Warrants, Announces Preliminary Q3 2023 Results, and Implements Streamlined Operational Plan (GlobeNewswire) -11.02%

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNGO

Bionano Genomics Inc

Upgrade your FINVIZ experience